IP Library › Assignment 025130/0816
Patent Assignment
Reel/Frame 025130/0816

Change of Address of Assignee

Recorded: 2010-10-13 Pages: 2
Assignor
INTERCEPT PHARMACEUTICALS, INC.
Executed: 2007-03-01
Assignee
INTERCEPT PHARMACEUTICALS, INC.
18 DESBROSSES STREET, NEW YORK, NEW YORK, 10013
Covered Property (1)
Bile Acid Derivatives as Fxr Ligands for the Prevention or Treatment of Fxr-Mediated Diseases or Conditions
Patent: 7,858,608 →
Application: 12/435,063 →
Publication: US 2010/0063018
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 30, 2010
From: PELLICCIARI, ROBERTO; PRUZANSKI, MARK
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025072/0095 →
Sponsored Research Agreement Sep 30, 2010
From: FIORUCCI, STEFANO
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 025086/0523 →
Notice of Joint Ownership Claim Mar 23, 2017
From: FIORUCCI, STEFANO, DR.
To: FIORUCCI, STEFANO, DR.
Reel/Frame 042072/0643 →
Security Interest Aug 18, 2021
From: INTERCEPT PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 057650/0772 →
Change of Address Aug 22, 2022
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 061297/0856 →
Release of Security Interest Jan 4, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 066662/0210 →